Disruption of epigenetic regulators of transcription is a central mechanism of oncogenesis. Many of the advances in the understanding of these mechanisms are attributable to the successful development of chromatin immunoprecipitation (ChIP) for in vivo detection of histone modifications as well as chromatin binding regulatory proteins. This is a powerful technique for analyzing histone modifications as well as binding sites for proteins that bind either directly or indirectly to DNA. Here we present two ChIP protocols. The first is particularly useful for identifying histone modifications or binding at specific, known genomic sites. The second, employing serial analysis of gene expression, is particularly powerful for the discovery of previously unidentified sites of modification or binding.
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technique is dependent on many variables, such as the specific antibody, cross-linking conditions, and sonication conditions that must be empirically determined. Here we present protocols for ChIP with PCR or Q-PCR detection as well as ChIP-SAGE approaches. A number of reviews have been published on ChIPon-chip (3, 4) and a number of companies now offer ChIP-onchip solutions. One excellent source for protocols and an overview of this approach is given in www.chiponchip.org . 2. 10% Paraformaldehyde stock: Microwave 18 mL of PBS in a 50-mL tube placed in a beaker with water until water starts to boil (leave lid of tube slightly ajar). Do the subsequent steps in a hood. Add 2 g of paraformaldehyde (wear a mask when weighing out) and 140 μ L of 1 M KOH. Vortex carefully until the paraformaldehyde dissolves. Add additional PBS to 20 mL (about 500 μ L). Cool to 37°C before use. Can be stored as frozen aliquots indefinitely.
3. DMP/DMSO/PBS: 20 mM DMP solution in 25% dimethyl sulfoxide (DMSO)/PBS (77.75 mg DMP + 3.75 mL DMSO + 11.25 mL PBS).
Dimethyl pimelimidate dihydrochloride (DMP, Sigma D8388).
5. Elution buffer prepared fresh either from EZ kit™ components or by dissolving 0.5 g SDS and 0.42 g NaHCO 3 (1% SDS, 0.1 M NaHCO 3 )in 50 mL sterile Milli-Q™ water. 10. Sph I-digested pZero-1™ (Invitrogen).
Electromax™ DH10Bs bacteria (Invitrogen).
The success of ChIP is highly dependent on the antibodies used, which must recognize formalin-fixed epitopes. One way of assessing the likelihood that antibodies will work for ChIP is to perform immunofluorescent staining of cells fixed under the same conditions used for ChIP. In addition, if there is a question of whether the immunoprecipitation is successful the ChIPped chromatin can be boiled in SDS loading buffer and analyzed by western blotting. Some of the antibodies that have been successfully used for ChIP are listed below.
1. Histone H3 dimethyl lysine 4 (Abcam: #ab7766).
2. Histone H3 trimethyl lysine 4 (Abcam: #ab8580).
3. Histone H3 trimethyl lysine 4 (Upstate Biotechnologies: #07-473).
4. Histone H3 dimethyl lysine 79 (Upstate Biotechnologies: #05-835).
5. Histone H3 trimethyl lysine 27 (Upstate Biotechnologies: 07-449).
6. Histone H3, polyacetylated (Upstate Biotechnologies: #06-599). 14. Histone H4 acetyl lysine 16 (Upstate Biotechnologies: #07-329).
1. Rbbp5 (Bethyl Laboratories, Montgomery, TX: cat no. A300-109A).
2. Menin (Bethyl: A300-105A). This protocol is a minor modification of the Upstate Biotechnology protocol that accompanies their chromatin IP kit. 1. Remove a bottle of dimethyl pimelimidate dihydrochloride from the freezer and allow it to warm to room temperature before opening (it is highly hygroscopic).
Rinse cells gently with PBS and then fix cells either directly on
the plate or in a 1.5-mL tube by rocking at room temperature for 1 h (for a 10-cm dish use 5 mL DMP/DMSO/PBS, for a 1.5-mL tube use 400 μ L DMP/DMSO/PBS).
3. Add 1% paraformaldehyde (in PBS) directly to the plate/tube for a final concentration of 2/3% paraformaldehyde (i.e., add 10 mL 1% paraformaldehyde to 5 mL of DMP solution or 800 μ L to 400 μ L solution).
4. Seal the plates with Parafilm™ or rotate in 1.5-mL tubes at room temperature in a fume hood for 5-20 h (empirically determine time for different proteins).
5. Spin down at 364 × g , 5 min and rinse cells with PBS being careful not to lose material on the walls of the tube.
6. Add lysis buffer and begin ChIP protocol. Alternatively, the pellet may be frozen at this point. The samples should be aspirated 3× through a 27G needle. The sonication conditions will also need to be increased empirically (for e.g., Bioruptor™ for 20 min on high with a 0.5-min cycle). Continue with step 4 in Subheading 3.1.2 .
1. Add 100 μ L of chromatin lysis buffer (+ protease inhibitors) per 5 × 10 5 MEF cells (or 5 × 10 6 or more cells per ChIP for "smaller" cell types) and place in 1.5-mL microfuge tube on ice for 10 min.
2. Syringe passage 3× with a 27-gauge needle; centrifuge briefly between passages if mixture gets foamy. Do the first and second passes and spin briefly at 15,000 × g , then follow with third pass. 3. Sonication conditions must be empirically determined depending upon the specific sonicator and the fixation conditions used. As an example, for a 10 min, 1% paraformaldehyde fixation, a Diagenode™ Bioruptor set at high for 10 min (0.5 min cycle) is usually sufficient for sonication of DNA to 200-700 bp. If using the DMP fixation outlined below, sonication should be increased to two cycles of 10-min each.
4. Spin at 15,000 × g for 20 min at 4°C. Transfer supernatant to a 15-mL tube and dilute 10× with chromatin dilution buffer plus protease inhibitors. Save several 50-μ L aliquots of diluted chromatin. These aliquots represent input and comprise about 5% of the total chromatin used per ChIP. These should be flash frozen and stored at -20°C to be processed along with the immunoprecipitated samples.
1. Add antibodies to tubes (usually 1-5 μ L/mL, depending on the antibody). One tube without antibody (or pre-immune serum if available) should be used as a no antibody control. We have not found a preclearing step to be necessary.
2. Rotate at 4°C overnight.
3. Collect immune complexes with 60 μ L of a 50:50 slurry of agaroseA (or agaroseG for mouse monoclonal antibodies) and salmon sperm DNA slurry (from kit) by rotating for 1 h at 4°C.
The slurry is viscous and should be gently mixed immediately before using and transferred using wide bore pipette tips. A different approach is required if the gene targets of interest are not known. One approach is the use of ChIP-on-chip on genome-wide arrays. Serial analysis of gene expression (SAGE), a technique for high-throughput analysis of gene expression, has also been used for high-throughput analysis of histone modifications and DNA binding proteins. SAGE is based on the principle that short sequence tags contain sufficient information for the identification of a transcript and the number of tags from a particular transcript reflects the absolute abundance of the transcript in the cell. In the modified SAGE protocol (Long-SAGE) (6) , the cDNA synthesized from the mRNA isolated from the cells is digested with Nla III restriction enzyme and ligated to a linker containing a class II restriction enzyme sequence (Mme I). Digestion with Mme I cleaves the DNA 21 bp away from its recognition site and releases a 21-bp tag from the cDNA. The short tags are concatenated to 1-2 kb molecules, which are then cloned and sequenced. ChIP coupled with SAGE has been used to analyze genome-wide histone modification patterns in yeast and human cells (7) (8) (9) . Because of the quantitative nature of SAGE, this procedure requires minimal normalization. Moreover, it does not require preselected probes and, therefore, can identify any genomic loci that are modified. The combination of this method with the recently developed high throughput sequencing techniques, such as massive parallel signature sequencing (MPSS), provides a comprehensive, quantitative, and economical method for analyzing genome-wide epigenetic modifications of the human genome. Stop the reaction by adding 400 μ L of 1×TE + 2 M NaCl.
12. Transfer the reaction mixture to an Eppendorf tube containing 1 mg of Dynabeads™ M280 (strepavidin). Mix at room temperature for 15 min.
13. Transfer the supernatant to a new tube containing 1 mg of Dynabeads™ M280 (strepavidin). Mix at room temperature for 15 min.
14. Repeat step 13 three times.
15. Transfer the supernatant to a new tube and purify the DNA using phenol-chloroform extraction and ethanol precipitation. 23. The sequences obtained either by the traditional sequencing method or the 454 high throughput technique are analyzed using the SAGE2000 v.4.5 program developed by the Johns Hopkins University to extract the 21 bp sequence tags and to quantify the tags. The sequence tags are then compared with a reference library generated from Nla III cutting sites in the human genomic sequence available at UCSC or NCBI databases.
Fixation conditions for ChIP must be determined empirically.
The optimal conditions appear to vary depending on whether the protein of interest (a) binds directly to a specific DNA sequence such as transcription factors, (b) binds directly to DNA but in a sequence-independent manner such as histones, or (c) binds to DNA only indirectly via interactions with complexes of proteins such as histone methyltransferases or members of nucleosome remodeling complexes ( Fig. 1 ) . Generally the fixation conditions should be minimized, especially when dealing with histones as lysine residues are structurally altered by fixation. For histone or histone modifications we have had good results with ChIP when cells are fixed for 10 min with 1% formaldehyde at 37°C. The same conditions work well with transcription factors that are directly bound to DNA as the efficiency for DNA:protein cross-linking is very high ( Fig. 1b ) .
2. When doing ChIP with proteins that are subunits of large molecular weight complexes, multiple protein:protein as well as protein:DNA fixation steps may be required ( Fig. 1c ) . In this case, the signal can often be increased with a multistep fixation procedure employing both a protein:protein crosslinker, such as DMP and then a long formaldehyde crosslinking step. These conditions can increase signal intensity nearly tenfold; however, the conditions need to be optimized because the background signal also increases. Sonication conditions must also be empirically determined. The longer the fixation protocol, the more difficult it will be to sonicate the DNA efficiently. We have found that passage of lysed chromatin through a 27G needle before sonication improves the efficiency of sonication. We recommend analyzing the sonicated DNA on agarose gels. For optimal ChIP experiments, DNA fragments should be between 200 and 1,000 bp with a mean fragment size of approximately 500 bp.
3. Although conventional PCR may be used for detection in ChIP, in practice, this approach only works well when the differences between signal and noise are significant. For subtle changes or for weaker ChIP signals, quantitative PCR offers many advantages including analysis in the linear range of the PCR reaction and for a rigorous analysis of IP efficiency. We routinely use TaqMan™ primer/probe sets or SYBR green™. Primer Express™ software (ABI) is helpful for designing primers or primer/probe sets, but care must be taken to visually inspect primers to make sure the GC content is between 20 and 80% and to make sure that the TaqMan probe does not
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start with a G. Both SYBR green™ and Taqman™ reactions generate curves that can be analyzed as discussed below. There is no uniformly agreed approach for quantification of ChIP results. The most common approach is to quantitate immunoprecipitation efficiency as an IP:Input ratio. The two main ways of doing this include using standard curves with a dilution series of an input sample, or comparing input vs. IP signal directly. The approaches yield similar results. For brevity we discuss the second approach. The amount of genomic DNA coprecipitated with antibody is calculated as a percentage of total input using the following formula ( Fig. 2 ) . A 50-μ L aliquot taken from each of 1 mL of sonicated, diluted chromatin before antibody incubation serves as the input (see protocol). The signal from the input samples represents 5% of the total chromatin used in each ChIP. C T values are determined by choosing threshold values in the linear range of each PCR reaction ( see Fig. 2 for a sample calculation).
4. In using Q-PCR for ChIP analysis, it is important to recognize that quantified values are not direct measures of absolute protein levels. The strength of the ChIP signal is dependent on multiple factors including the strength of the antibody:epitope interaction, the accessibility of the epitope after fixation, as well as the absolute amount of protein present at the locus. A second important factor is that background signal is inherent to ChIP experiments even in the absence of antibody, raising the question of how to distinguish between background and "real" signal. Contamination by cloned DNA representing target sequences when these are also being handled can be a major impediment to successful ( Fig. 3a ) . At the Gapdh locus, which microarray experiments suggest is not regulated by Mll, the signal is below 0.05% in both Mll +/+ and Mll −/− cells, indicating that this locus is not bound by Mll. , grey bars ). A strong signal is seen at the Hoxa9 locus in Mll +/+ cells and this signal is reduced to below 0.05% in Mll −/− cells indicating that this is in the background range for this antibody. Binding at GAPDH is below this threshold in both cell types indicating that it is negative for Mll binding, at least at the specific region of GAPDH examined. ( b ) MLL-ENL-ER, a MLL fusion protein fused to the estrogen receptor, is active only in the presence of 4-OHT (10) . Ab10 recognizes the fusion protein and shows a strong binding signal at Hoxa9 in the presence of 4-OHT ( black bar ). In the absence of 4-OHT, signal is drastically reduced but not completely abolished ( striped bar ). Ab1, ( grey bars ) which does not recognize the fusion protein, gives a similar signal as IgG ( white bars ) .
Conditional models are particularly powerful for ChIP experiments ( Figs. 3 and 4 ) . As an example, when fused to the estrogen receptor (ER), the MLL-ENL fusion protein is only active in the presence of tamoxifen (4-OHT). When ChIP is performed with the antibody Ab10, which recognizes the ER present in MLL-ENL, a strong signal is seen at Hoxa9 ( Fig. 3b , black bar) in the presence, but not absence, of 4-OHT ( Fig. 3b , striped fusion protein (Ab1 and general IgG) give a signal again below 0.05% (white and grey bars) and Ab10 in both + and − 4-OHT treated cells gives a signal below 0.05% at Gapdh , indicating that the residual binding seen at Hoxa9 is likely "real."
It is not always possible to include all of these controls. Our general experience is that different antibodies with different fixation conditions generally give a background, nonspecific ChIP signal in the range 0.01-0.08% of input ( see Fig. 5 ). As a rule of thumb, any signal over 0.1% of input is likely to be significant, while below that is likely in the range of background signal.
Another approach that is particularly informative is to generate a series of primers across the locus to be examined. The graphical representation of the quantitative ChIP data can provide additional information and a higher degree of confidence that small changes in binding seen are significant ( see Fig. 4 ).
